Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
Calderon SN, Rice KC, Rothman RB, Porreca F, Flippen-Anderson JL, Kayakiri H, Xu H, Becketts K, Smith LE, Bilsky EJ, Davis P, Horvath R (1997). „Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands”. J. Med. Chem.40 (5): 695–704. DOI:10.1021/jm960319n. PMID9057856.
Broom D. C., Nitsche JF, Pintar JE, Rice KC, Woods JH, Traynor JR (November 2002). „Comparison of Receptor Mechanisms and Efficacy Requirements for delta -Agonist-Induced Convulsive Activity and Antinociception in Mice”. Journal of Pharmacology and Experimental Therapeutics303 (2): 723–729. DOI:10.1124/jpet.102.036525. PMID12388657.
Broom D, Jutkiewicz EM, Folk JE, Traynor JR, Rice KC, Woods JH (June 2002). „Nonpeptidic δ-opioid Receptor Agonists Reduce Immobility in the Forced Swim Assay in Rats”. Neuropsychopharmacology26 (6): 744–755. DOI:10.1016/S0893-133X(01)00413-4. PMID12007745.
Torregrossa Mary M, Isgor Ceylan, Folk John E, Rice Kenner C, Watson Stanley J, Woods James H (April 2004). „The δ-Opioid Receptor Agonist (+)BW373U86 Regulates BDNF mRNA Expression in Rats”. Neuropsychopharmacology29 (4): 649–659. DOI:10.1038/sj.npp.1300345. PMID14647482.
Patel H, Hsu A, Moore J, Gross GJ (August 2001). „BW373U86, a δ Opioid Agonist, Partially Mediates Delayed Cardioprotection via a Free Radical Mechanism that is Independent of Opioid Receptor Stimulation”. Journal of Molecular and Cellular Cardiology33 (8): 1455–1465. DOI:10.1006/jmcc.2001.1408. PMID11448134.
Patel H, Hsu AK, Gross GJ (May 2004). „COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat”. Life Sciences75 (2): 129–140. DOI:10.1016/j.lfs.2003.10.036. PMID15120566.
Gross E. R., Hsu A. K., Gross G. J. (July 2007). „GSK3β inhibition and KATP channel opening mediate acute opioid-induced cardioprotection at reperfusion”. Basic Research in Cardiology102 (4): 341–349. DOI:10.1007/s00395-007-0651-6. PMID17450314.
Calderon SN, Rice KC, Rothman RB, Porreca F, Flippen-Anderson JL, Kayakiri H, Xu H, Becketts K, Smith LE, Bilsky EJ, Davis P, Horvath R (1997). „Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands”. J. Med. Chem.40 (5): 695–704. DOI:10.1021/jm960319n. PMID9057856.
Thomas JB, Herault XM, Rothman RB, Atkinson RN, Burgess JP, Mascarella SW, Dersch CM, Xu H i dr.. (March 2001). „Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-(N-substituted-4-piperidinyl)arylamino-N,N-diethylbenzamides.”. Journal of medicinal chemistry44 (6): 972–87. PMID11300879.
Chang KJ, Rigdon GC, Howard JL, McNutt RW (November 1993). „A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86”. The Journal of pharmacology and experimental therapeutics267 (2): 852–7. PMID8246159.
Broom D. C., Nitsche JF, Pintar JE, Rice KC, Woods JH, Traynor JR (November 2002). „Comparison of Receptor Mechanisms and Efficacy Requirements for delta -Agonist-Induced Convulsive Activity and Antinociception in Mice”. Journal of Pharmacology and Experimental Therapeutics303 (2): 723–729. DOI:10.1124/jpet.102.036525. PMID12388657.
Broom D, Jutkiewicz EM, Folk JE, Traynor JR, Rice KC, Woods JH (June 2002). „Nonpeptidic δ-opioid Receptor Agonists Reduce Immobility in the Forced Swim Assay in Rats”. Neuropsychopharmacology26 (6): 744–755. DOI:10.1016/S0893-133X(01)00413-4. PMID12007745.
Torregrossa Mary M, Isgor Ceylan, Folk John E, Rice Kenner C, Watson Stanley J, Woods James H (April 2004). „The δ-Opioid Receptor Agonist (+)BW373U86 Regulates BDNF mRNA Expression in Rats”. Neuropsychopharmacology29 (4): 649–659. DOI:10.1038/sj.npp.1300345. PMID14647482.
Comer SD, Hoenicke EM, Sable AI, McNutt RW, Chang KJ, De Costa BR, Mosberg HI, Woods JH (November 1993). „Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice”. The Journal of pharmacology and experimental therapeutics267 (2): 888–95. PMID8246164.
O'Neill SJ, Collins MA, Pettit HO, McNutt RW, Chang KJ (July 1997). „Antagonistic modulation between the delta opioid agonist BW373U86 and the mu opioid agonist fentanyl in mice”. The Journal of pharmacology and experimental therapeutics282 (1): 271–7. PMID9223564.
Su YF, McNutt RW, Chang KJ (December 1998). „Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception”. The Journal of pharmacology and experimental therapeutics287 (3): 815–23. PMID9864259.
Patel H, Hsu A, Moore J, Gross GJ (August 2001). „BW373U86, a δ Opioid Agonist, Partially Mediates Delayed Cardioprotection via a Free Radical Mechanism that is Independent of Opioid Receptor Stimulation”. Journal of Molecular and Cellular Cardiology33 (8): 1455–1465. DOI:10.1006/jmcc.2001.1408. PMID11448134.
Patel H, Hsu AK, Gross GJ (May 2004). „COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat”. Life Sciences75 (2): 129–140. DOI:10.1016/j.lfs.2003.10.036. PMID15120566.
Gross E. R., Hsu A. K., Gross G. J. (July 2007). „GSK3β inhibition and KATP channel opening mediate acute opioid-induced cardioprotection at reperfusion”. Basic Research in Cardiology102 (4): 341–349. DOI:10.1007/s00395-007-0651-6. PMID17450314.